Showing latest transactions and SEC Form 4 filings for LRMR.
11 results.
| X | Filing Date | Trade Date | Ticker | Company Name | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 16:30:16 | 2026-11-16 | LRMR | Larimar Therapeutics, Inc. | Clayton Russell | Chief Medical Officer | P - Purchase | $3.01 | +3,322 | 74,765 | +5% | +$9,999 | |
| 2026-11-16 17:33:23 | 2026-11-16 | LRMR | Larimar Therapeutics, Inc. | SHERMAN JEFFREY W | Director | P - Purchase | $3.06 | +3,289 | 8,289 | +66% | +$10,058 | |
| 2026-11-12 21:32:19 | 2026-11-12 | LRMR | Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Director | P - Purchase | $2.67 | +70,000 | 944,231 | +8% | +$187,082 | |
| 2026-11-12 18:02:53 | 2026-11-11 | LRMR | Larimar Therapeutics, Inc. | BEN-MAIMON CAROLE | President and CEO, Director | P - Purchase | $2.77 | +18,050 | 542,104 | +3% | +$49,953 | |
| 2026-11-12 18:01:32 | 2026-11-11 | LRMR | Larimar Therapeutics, Inc. | THOMAS FRANK E | Director | P - Purchase | $2.73 | +8,000 | 15,000 | +114% | +$21,800 | |
| 2026-11-12 18:00:54 | 2026-11-11 | LRMR | Larimar Therapeutics, Inc. | Truitt Joseph | Director | P - Purchase | $2.80 | +3,500 | 6,250 | +127% | +$9,792 | |
| 2026-11-12 18:00:18 | 2026-11-11 | LRMR | Larimar Therapeutics, Inc. | Harlow John B. Jr. | President and COO | P - Purchase | $2.80 | +17,800 | 67,800 | +36% | +$49,918 | |
| 2026-11-12 17:56:59 | 2026-11-11 | LRMR | Larimar Therapeutics, Inc. | Celano Michael | Chief Financial Officer | P - Purchase | $2.71 | +18,460 | 234,245 | +9% | +$49,992 | |
| 2026-11-12 17:55:03 | 2026-11-11 | LRMR | Larimar Therapeutics, Inc. | Shankar Gopi | Chief Development Officer | P - Purchase | $2.71 | +5,000 | 81,443 | +7% | +$13,549 | |
| D | 2026-10-01 16:27:13 | 2026-09-29 | LRMR | Larimar Therapeutics, Inc. | Harlow John B. Jr. | President and COO | A | $0.00 | +850,000 | 50,000 | 0% | $0 |